logo-loader
viewTrutrace Technologies Inc.

Full interview: TruTrace Technologies and Shopper Drug Mart finish phase 1 verification testing

TrueTrace Technologies (CSE: TTT; OTCQB: TTTSF) President and CEO Robert Galarza joined Steve Darling on Skype from Seattle with news the company, along with their partner, Shopper Drug Mart completed phase 1 of their Pilot Program designed to increase transparency and product identification within the medical cannabis industry.

Galarza also talked about the beginning of phase 2 and the very well know the company they will be working with. 

Quick facts: Trutrace Technologies Inc.

Price: 0.085 CAD

CSE:TTT
Market: CSE
Market Cap: $7.06 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Trutrace Technologies Inc. named herein, including the promotion by the Company of Trutrace Technologies Inc. in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

13 hours, 39 minutes ago

2 min read